Peter Mougey is a shareholder and the Chair of Levin Papantonio’s Securities and Business Litigation department. He concentrates his practice in the areas of complex litigation, financial services, and securities litigation, and whistleblower or qui tam litigation. Mr. Mougey has been recognized as one of Florida’s top 100 trial lawyers and a Florida Super Lawyer and has dedicated his career to championing individuals’ rights against the world’s largest companies.
His peers have rated him AV Preeminent, the highest possible rating. Mr. Mougey has represented over 1,500 state, municipal, and institutional entities, as well as tribal sovereign nations, in litigation and arbitration around the globe. In addition, he has represented more than 3,000 individual fraud victims in state and federal court and arbitrations.
Most recently, in the National Prescription Opiate Litigation MDL, Mr. Mougey was selected to serve as Co-Lead of the Distributor case and serves on the Plaintiff’s Executive Committee in what has been called “the largest and most complex case in the history of jurisprudence” by the Washington Post. He also was recently credited as one of the key negotiators in the $26 billion settlement with opioid manufacturer Johnson & Johnson (J&J) and the “Big Three” drug distributors AmerisourceBergen, Cardinal Health, and McKesson.
Mr. Mougey routinely lectures on issues confronting the legal and business industry including, “Bet the Company Litigation,” Broker-Dealer Regulation, Structured Finance, the Dodd-Frank Wall Street Reform Act, Managing Large Datasets for use in Litigation, and Quantitative Modeling. He is frequently quoted in the national press including The Wall Street Journal, Forbes, New York Times, The Los Angeles Times, Washington Post, Barron’s, Kiplinger, Business Week, and Investment News.